Results 121 to 130 of about 1,927 (159)

Cellular determinants of raltegravir exposure [PDF]

, 2012
openaire   +2 more sources

Drug-Drug Interactions Between Raltegravir and Pravastatin in Healthy Volunteers

, 2010
Matthijs van Luin, Angela Colbers, E.W.J. van Ewijk-Beneken Kolmer, C.P.W.G.M. Verwey-van Wissen, B.J.J.W. Schouwenberg, Arjen Hoitsma, Hugo G da Silva, David M. Burger   +7 more
openalex   +1 more source

[Genetic barrier to antiretroviral drug-resistance. Focus on raltegravir, the first integrase inhibitor].

, 2010
Constance Delaugerre
openalex   +1 more source

Raltegravir 800 mg once‐daily is efficacious in already virologically suppressed patients [PDF]

, 2012
Derek Ward, Robert Grant
openalex   +1 more source

Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes

, 2011
Kendra E. Hightower, Ruolan Wang, Felix Deanda, Brian A. Johns, Kurt Weaver, Yingnian Shen, Ginger H. Tomberlin, H. Luke Carter, Timothy M Broderick, Sigethy Scott, Takahiro Seki, Masanori Kobayashi, Mark Underwood   +12 more
openalex   +1 more source

Switch from Enfuvirtide to Raltegravir Lowers Plasma Concentrations of Darunavir and Tipranavir: a Pharmacokinetic Substudy of the EASIER-ANRS 138 Trial

, 2011
Lauriane Goldwirt, Joséphine Braun, Nathalie De Castro, Isabelle Charreau, Aurélie Barrail‐Tran, Constance Delaugerre, François Raffi, Caroline Lascoux‐Combe, J Aboulker, Anne‐Marie Taburet, Jean‐Michel Molina   +10 more
openalex   +1 more source

Reply to comment on ‘pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients’

, 2011
Aurélie Barrail‐Tran, Yazdan Yazdanpanah, Lauriane Goldwirt, Geneviève Chêne, Céline Colin, Christophe Piketty, Diane Bollens, Christine Katlama, Diane Descamps, Jean‐Michel Molina, Catherine Fagard, Anne‐Marie Taburet   +11 more
openalex   +1 more source

Raltegravir, Etravirine, and Ritonavir-Boosted Darunavir

, 2011

openalex   +1 more source

Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients

, 2011

openalex   +1 more source

A Randomized Study of Pharmacokinetics, Efficacy, and Safety of 2 Raltegravir Plus Atazanavir Strategies in ART-Treated Adults

, 2012
Dianne Carey, Sarah Pett, Mark Bloch, Handan Wand, Karen MacRae, Kate Beileiter, John E. Ray, Mark Boyd, Sean Emery, David A. Cooper   +9 more
openalex   +1 more source